CEO: Li Fangping
Founders: Li Fangping
Years active: 2006 -
Nurotron Biotechnology is a medical device company that designs, develops and markets neurostimulation systems. The company’s flagship system is the Venus Cochlear Implant System, a safe, reliable and effective solution for children and adults suffering from severe and profound hearing loss. Nurotron’s patent portfolio also includes an auditory brainstem implant, artificial retina system, and systems to treat paralysis due to stroke.
last updated: June 10th, 2021 7:14am